Tenofovir alafenamide
- Level
- Commodity
- Parent
- 51343500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343508This classification denotes a reverse transcriptase inhibitor and purine antagonist C21H29N6O5P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EL9943AG5J, chemically known as l-alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester, but more generally known as tenofovir alafenamide, which bears US NIH Compound Identifier 9574768. Most nations, for tariff and trade purposes, schedule tenofovir alafenamide under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR ALAFENAMIDE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CN1CNC2C1NCNC2N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3CCCCC3.
Same parent
Under 51343500 · 12Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.